NON-RESECTABLE HEPATOCELLULAR CARCINOMA

Clinical trials for NON-RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NON-RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for NON-RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for Tough-to-Treat bile duct cancer?

Disease control Completed

This study tested if a new combination of chemotherapy drugs (nal-IRI with 5-FU) could better control advanced bile duct cancer compared to a standard treatment. It involved 93 adults whose cancer could not be removed by surgery. The main goal was to see if the new combination co…

Matched conditions: NON-RESECTABLE HEPATOCELLULAR CARCINOMA

Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

NON-RESECTABLE HEPATOCELLULAR CARCINOMA

Get alerted when new NON-RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

New hope for Tough-to-Treat bile duct cancer?